Optimized antiviral therapy in chronic hepatitis B: A randomized, open-label, multicenter, controlled trial.
Phase of Trial: Phase IV
Latest Information Update: 22 Apr 2016
At a glance
- Drugs Lamivudine (Primary) ; Adefovir dipivoxil
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Planned end date changed from 30 May 2009 to 1 Nov 2010 as reported by Chinese Clinical Trial Register.
- 24 Jun 2009 New trial record